Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-778-7 | CAS number: 150-90-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
Reproductive toxicity study
Based on the data available from different studies, NOAEL for test material was considered to be 1000mg/kg /day for reproductive toxicity, when male and female rats were treated with test material orally. Thus, comparing this value with the criteria of CLP regulation test material is not likely to classify as reproductive toxicant.
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- Experimental data from various test chemicals
- Justification for type of information:
- Weight of evidence approach based on the available information from various test chemicals.
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- WoE report is based on reproductive toxicity studies on rats
- GLP compliance:
- not specified
- Limit test:
- no
- Justification for study design:
- No data available
- Species:
- rat
- Strain:
- other: 1.Crj: CD(SD) 2.Sprague-Dawley
- Details on species / strain selection:
- No data available
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 2.Details on test animals and env. conditions
TEST ANIMALS
- Source: Laboratory Animal Unit,
Faculty of Medicine, Khon Kaen University,
Khon Kaen, Thailand.
- Age at study initiation: 8 weeks
- Weight at study initiation: (P) Males: x-x g; Females: x-x g; (F1) Males: x-x g; Females: x-x g
- Fasting period before study:
- Housing: Animals were kept in groups of four in cages
(60×30×20)
- Use of restrainers for preventing ingestion (if dermal): yes/no
- Diet (e.g. ad libitum): food ad libitum
- Water (e.g. ad libitum): water ad libitum
- Acclimation period: - Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- Water for injection
- Details on exposure:
- 1.Details on exposure
PREPARATION OF DOSING SOLUTIONS:
Test materials dissolved in Water for injection
DIET PREPARATION
- Rate of preparation of diet (frequency):No data available
- Mixing appropriate amounts with (Type of food )
- Storage temperature of food: No data available
VEHICLE
- Justification for use and choice of vehicle (if other than water): Test material dissolved in Water for injection
- Concentration in vehicle: 0 (vehicle), 100, 300, 1000 mg/kg
- Amount of vehicle (if gavage):
- Lot/batch no. (if required): No data available
- Purity: No data available
2.Details on exposure
PREPARATION OF DOSING SOLUTIONS:
Test materials dissolved in distilled water
DIET PREPARATION
- Rate of preparation of diet (frequency):No data available
- Mixing appropriate amounts with (Type of food )
- Storage temperature of food: No data available
VEHICLE
- Justification for use and choice of vehicle (if other than water): Test material dissolved in distilled water
- Concentration in vehicle: 0 (vehicle),250, 3000, 6000mg/kg
- Amount of vehicle (if gavage):
- Lot/batch no. (if required): No data available
- Purity: No data available - Details on mating procedure:
- No data available
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 1.Males, 52 days
Females, from 14 days before mating to day 4 of lactation
2.30 days - Frequency of treatment:
- Once daily
- Details on study schedule:
- No data available
- Remarks:
- Study 1.
0 (vehicle), 100, 300, 1000 mg/kg
Study 2.
0 (vehicle),250, 3000, 6000 mg/kg - No. of animals per sex per dose:
- Study 1.
Total:96
0 mg/kg bw/day:12 male and 12 female
100mg/kg bw/day:12 male and 12 female
300mg/kg bw/day:12 male and 12 female
1000 mg/kg bw/day:12 male and 12 female
Study 2.
Total:32
0 mg/kg bw/day:8 male
250mg/kg bw/day:8 male
3000mg/kg bw/day:8 male
6000 mg/kg bw/day:8 male - Control animals:
- yes, concurrent vehicle
- Details on study design:
- No data available
- Positive control:
- No data available
- Parental animals: Observations and examinations:
- 1.Parental animals observation and examinations
CAGE SIDE OBSERVATIONS: yes
DETAILED CLINICAL OBSERVATIONS:
Time schedule:
BODY WEIGHT: Yes
Time schedule for examinations:
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):.
Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes / No / No data: No data available
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No data
Time schedule for examinations
2.Parental animals observation and examinations
CAGE SIDE OBSERVATIONS: yes
DETAILED CLINICAL OBSERVATIONS:
Time schedule:
BODY WEIGHT: Yes
Time schedule for examinations:
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):.
Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes / No / No data: No data available - Oestrous cyclicity (parental animals):
- yes
- Sperm parameters (parental animals):
- 2.Parameters examined in male parental generations:
testis weight, epididymis weight, daily sperm production, sperm count in testes, sperm count in epididymides, enumeration of cauda epididymal sperm reserve, sperm motility, sperm morphology were observed - Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: [yes/no]
- If yes, maximum of [...] pups/litter ([...]/sex/litter as nearly as possible); excess pups were killed and discarded.
PARAMETERS EXAMINED
The following parameters were examined in [F1] offspring:
number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, physical or behavioural abnormalities, were observed.
GROSS EXAMINATION OF DEAD PUPS: no
[no / yes, for external and internal abnormalities; possible cause of death was/was not determined for pups born or found dead.]
ASSESSMENT OF DEVELOPMENTAL NEUROTOXICITY:No
ASSESSMENT OF DEVELOPMENTAL IMMUNOTOXICITY:No - Postmortem examinations (parental animals):
- Postmortem examinations (Parent Animal)
SACRIFICE:
Male animals: yes on 53 days
Female animals: yes on day 5 of lactation
All surviving animals [describe when, e.g. after the last litter of each generation was weaned :
GROSS NECROPSY: yes
HISTOPATHOLOGY / ORGAN WEIGHTS - Postmortem examinations (offspring):
- SACRIFICE
- The F1 offspring were sacrificed at [5] days of age.
- These animals were subjected to postmortem examinations (macroscopic and/or microscopic examination) as follows:
GROSS NECROPSY
- Gross necropsy consisted of [external examinations ]
HISTOPATHOLOGY / ORGAN WEIGTHS : No
The tissues indicated in Table [#] were prepared for microscopic examination and weighed, respectively. - Statistics:
- 2.One-way ANOVA and Student’s t-test were used to examine the significant differences between two or more sets of data, and between two data points, respectively, using the program of Sigma Stat version 3.1.1. All quantitative results are presented as the mean ± SD.
- Reproductive indices:
- Yes
- Offspring viability indices:
- yes
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- No treatment-related clinical signs were observed
- Dermal irritation (if dermal study):
- not specified
- Mortality:
- no mortality observed
- Description (incidence):
- No deaths were observed in any treatment group in either sex
- Body weight and weight changes:
- not specified
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- No marked changes in histology were noted in the testes of rats receiving 250mg/kg body weight of test material as compared with the control group However, a mild slouching of spermatogenic cells in the seminiferous tubular lumen was observed in approximately 10-15% of the seminiferous tubules obtained from eight animals administered with 3000mg /kg body weight of test material Moreover, mild sloughing of such seminiferous tubules with some vacuolization and some shrinkage of the interstitial tissues with wider empty spaces were noticed in approximately 40-45% of rats administered with 6000mg /kg body weight of test material
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- effects observed, treatment-related
- Description (incidence and severity):
- When compared to the control, the plasma testosterone levels were significantly lowered in 3000mg /kg body weight of test material (p<0.05) and of 6000mg/kg body weight of test material (p<0.01),whereas the testosterone levels in rats with 250mg /kg body weight of test material were normal.
- Reproductive function: oestrous cycle:
- no effects observed
- Description (incidence and severity):
- No adverse effects were observed in terms of the estrus cycle.In the observation of estrous cycle, there was no intergroup difference in the mean estrous cycle. The abnormal estrous cycle was observed in 1 animal each in the 100 and 1000 mg/kg groups. There was no intergroup difference in the incidence of abnormal estrous cycle.
- Reproductive function: sperm measures:
- effects observed, treatment-related
- Description (incidence and severity):
- among the groups of rats treated with all doses of test material. In contrast, the epididymis plus vas deferens and the seminal vesicle of rats treated group 6000mg/kg were smaller than those of the control, as well as the two rat groups treated with 250, and 3000mg/kg body
weight.
The administration of 250 and 3000mg /kg body weight of test material did not affect the epididymal sperm concentration when compared with the control group. In contrast, the epididymal sperm concentration was significantly decreased in the 6000mg /kg body weight group, compared with the control or two lower dose groups. In the acrosome reaction assays, there was no statistically significant difference between the control and three different treated groups (p>0.05). - Reproductive performance:
- no effects observed
- Description (incidence and severity):
- Copulation and conception were all established, and both the copulation index and the fertility index were 100% in all groups.The gestation period was significantly shortened in the 100 and 1000 mg/kg groups compared with the control group. There was no abnormality in the conditions of parturition, and the numbers of corpora lutea, implantation sites, delivered offspring and live delivered offspring showed almost the same values. There were no intergroup differences in the delivery index, implantation index, parturition index, live birth index, sex ratio and viability index of neonates on day 4 of lactation
- Dose descriptor:
- NOAEL
- Effect level:
- > 1 000 - <= 3 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- clinical signs
- mortality
- reproductive function (oestrous cycle)
- reproductive function (sperm measures)
- reproductive performance
- Remarks on result:
- other: No effects on reproductive performance
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- No treatment-related clinical signs were observed
- Dermal irritation (if dermal study):
- not specified
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- Body weight during lactation period was significantly low on days 0 and 4 of lactation in males and day 4 in females in the 100 mg/kg group and on day 4 in males in the 300 mg/kg group, which was the change not associated with the dose.
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- no effects observed
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- No abnormal findings related to the test substance were noted on external examination,
- Histopathological findings:
- not specified
- Other effects:
- not specified
- Behaviour (functional findings):
- not specified
- Developmental immunotoxicity:
- not specified
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- viability
- sexual maturation
- clinical signs
- mortality
- body weight and weight gain
- gross pathology
- Remarks on result:
- other: overall no effects on developmental parameters
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Reproductive effects observed:
- not specified
- Treatment related:
- not specified
- Conclusions:
- No Observed Adverse Effect Level (NOAEL) for maternal and foetal toxicity was considered to be 1000mg/kg/day. When male and female Crj: CD(SD) rats treated with test chemical orally.
- Executive summary:
Data available from different studies were reviewed to determine the reproductive toxicity of testchemical.The studies are as mentioned below:
Study 1
The one generation reproductive toxicity study of test chemical was performed in male and femaleCrj: CD(SD) rats. The test material was dissolved in Water for injection and administered in dose concentration 0 (vehicle), 100, 300, 1000 mg/kg to Males for 52 days and Females from 14 days before mating to day 4 of lactation. Each dose group contain 12 male and 12 female. All the animals were observed for clinical signs and body weight changes. Males were scarified on day 53 while females were killed on day 5 of lactation.
No treatment-related clinical signs were observed in parents as well as offspring.No deaths were observed in any treatment group in either sex. Copulation and conception were all established, and both the copulation index and the fertility index were 100% in all groups. In the observation of estrous cycle, there was no intergroup difference in the mean estrous cycle. The abnormal estrous cycle was observed in 1 animal each in the 100 and 1000 mg/kg groups. There was no intergroup difference in the incidence of abnormal estrous cycle. The gestation period was significantly shortened in the 100 and 1000 mg/kg groups compared with the control group. There was no abnormality in the conditions of parturition, and the numbers of corpora lutea, implantation sites, delivered offspring and live delivered offspring showed almost the same values. There were no intergroup differences in the delivery index, implantation index, parturition index, live birth index, sex ratio and viability index of neonates on day 4 of lactation. Body weight during lactation period was significantly low on days 0 and 4 of lactation in males and day 4 in females in the 100 mg/kg group and on day 4 in males in the 300 mg/kg group, which was the change not associated with the dose.No abnormal findings related to the test substance were noted on external examination. HenceNo Observed Adverse Effect Level (NOAEL) for maternal and foetal toxicity was considered to be 1000mg/kg/day.When male and female Crj: CD(SD) rats treated with test chemical orally.
Study 2
In reproductive toxicity study,the sensitivity of the testis, epididymis, seminal vesicle, and sperm acrosome reaction (AR) to test chemical in Sprague-dawley male rats (8-week-old) were determined. The test material in dose concentration0 (vehicle), 250, 3000, 6000 mg/kg were administered by oral gavage routetwice a day (between 0 and 8 h) half of the given concentrations of test material for 30 days. On the day after the termination of test doseadministration, all the animals were euthanized by cervical dislocation and gently sacrificed to collect the male reproductive organs (testes (TE), epididymis (EP), vas deferens (VD), and seminal vesicle (SV).Then, the organs of all groups were observed for gross lesions and were subsequently removed, cleaned of fats, and weighed. Tissues of TE, EP with VD, and SV were extirpated from the right side and they were Fixed with 10% formalin in PBS (pH 7.4), and embedded in paraffin, and sectioned at 4-6 µm thick and stained with hematoxylin-eosin (H and E). Plasma testosterone concentration was measured by enzymatic immunoassay ,Rat sperms were collected from the left caudal epididymis plus vas deferens and placed into 1 ml phosphate buffered saline(PBS, 37°C, pH 7.4) and further centrifuged (500 xg, 37°C, 5 min.) to separate the sperm pellet from the epididymal fluidIn comparison with the control group, no marked differences were found in the size, shape, and surface features of the testes among the groups of rats treated with all doses of test material , In contrast, the epididymis plus vas deferens and the seminal vesicle of rats treated group 6000mg/kg were smaller than those of the control, as well as the two rat groups treated with 250, and 3000mg/kg body weight
The administration of 250 and 3000mg /kg body weight of test material did not affect the epididymal sperm concentration when compared with the control group. In contrast, the epididymal sperm concentration was significantly decreased in the 6000mg /kg body weight group, compared with the control or two lower dose groups. In the acrosome reaction assays, there was no statistically significant difference between the control and three different treated groups (p>0.05). No significant differences were found among testes of 250, 3000, 6000 mg/kg groups as compared with the control group (p>0.05) The weight of the epididymis plus vas deferens was significantly decreased only in the 6000mg /kg body weight of group as compared with the control (p<0.05), while the weight of the seminal vesicle decreased in all treated groups with a marked decrease in the 6000mg/kg body weight of MSG group (p<0.01). No marked changes in histology were noted in the testes of rats receiving 250mg/kg body weight of test material as compared with the control group However, a mild slouching of spermatogenic cells in the seminiferous tubular lumen was observed in approximately 10-15% of the seminiferous tubules obtained from eight animals administered with 3000mg /kg body weight of test material Moreover, mild sloughing of such seminiferous tubules with some vacuolization and some shrinkage of the interstitial tissues with wider empty spaces were noticed in approximately 40-45% of rats administered with 6000mg /kg body weight of test material. When compared to the control, the plasma testosterone levels were significantly lowered in 3000mg /kg body weight of test material (p<0.05) and of 6000mg/kg body weight of test material (p<0.01),whereas the testosterone levels in rats with 250mg /kg body weight of test material were normal. HenceNo Observed Adverse Effect Level (NOAEL) was considered to be below 3000mg/kg/day as no significant difference was observed at male reproductive function, whenmaleSprague-dawleyrats treated with test chemical orally for 30 days. Butthe consumption of high dose test material must be avoided because it may cause partial infertility in male.
Based on the data available from different studies, test material did not showedreproductive toxicityat dose concentration 1000mg/kg /day. when male and female rats were treated with test material orally,Thus, comparing this value with the criteria ofCLP regulationtest materialis not likelyto classify as reproductive toxicant.
Reference
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- Data is Klimicsh 2 and from authoritative database
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Reproductive toxicity study
Data available from different studies were reviewed to determine the reproductive toxicity of test chemical.The studies are as mentioned below:
Study 1
The one generation reproductive toxicity study of test chemicalwas performed in male and femaleCrj: CD(SD) rats. The test material was dissolved in Water for injection and administered in dose concentration 0 (vehicle), 100, 300, 1000 mg/kg to Males for 52 days and Females from 14 days before mating to day 4 of lactation. Each dose group contain 12 male and 12 female. All the animals were observed for clinical signs and body weight changes. Males were scarified on day 53 while females were killed on day 5 of lactation.
No treatment-related clinical signs were observed in parents as well as offspring.No deaths were observed in any treatment group in either sex. Copulation and conception were all established, and both the copulation index and the fertility index were 100% in all groups. In the observation of estrous cycle, there was no intergroup difference in the mean estrous cycle. The abnormal estrous cycle was observed in 1 animal each in the 100 and 1000 mg/kg groups. There was no intergroup difference in the incidence of abnormal estrous cycle. The gestation period was significantly shortened in the 100 and 1000 mg/kg groups compared with the control group. There was no abnormality in the conditions of parturition, and the numbers of corpora lutea, implantation sites, delivered offspring and live delivered offspring showed almost the same values. There were no intergroup differences in the delivery index, implantation index, parturition index, live birth index, sex ratio and viability index of neonates on day 4 of lactation. Body weight during lactation period was significantly low on days 0 and 4 of lactation in males and day 4 in females in the 100 mg/kg group and on day 4 in males in the 300 mg/kg group, which was the change not associated with the dose.No abnormal findings related to the test substance were noted on external examination. HenceNo Observed Adverse Effect Level (NOAEL) for maternal and foetal toxicity was considered to be 1000mg/kg/day.When male and female Crj: CD(SD) rats treated with test chemicalorally.
Study 2
In reproductive toxicity study,the sensitivity of the testis, epididymis, seminal vesicle, and sperm acrosome reaction (AR) to test chemical in Sprague-dawley male rats (8-week-old) were determined. The test material in dose concentration0 (vehicle), 250, 3000, 6000 mg/kg were administered by oral gavage routetwice a day (between 0 and 8 h) half of the given concentrations of test material for 30 days. On the day after the termination of test doseadministration, all the animals were euthanized by cervical dislocation and gently sacrificed to collect the male reproductive organs (testes (TE), epididymis (EP), vas deferens (VD), and seminal vesicle (SV).Then, the organs of all groups were observed for gross lesions and were subsequently removed, cleaned of fats, and weighed. Tissues of TE, EP with VD, and SV were extirpated from the right side and they were Fixed with 10% formalin in PBS (pH 7.4), and embedded in paraffin, and sectioned at 4-6 µm thick and stained with hematoxylin-eosin (H and E). Plasma testosterone concentration was measured by enzymatic immunoassay ,Rat sperms were collected from the left caudal epididymis plus vas deferens and placed into 1 ml phosphate buffered saline(PBS, 37°C, pH 7.4) and further centrifuged (500 xg, 37°C, 5 min.) to separate the sperm pellet from the epididymal fluidIn comparison with the control group, no marked differences were found in the size, shape, and surface features of the testes among the groups of rats treated with all doses of test material , In contrast, the epididymis plus vas deferens and the seminal vesicle of rats treated group 6000mg/kg were smaller than those of the control, as well as the two rat groups treated with 250, and 3000mg/kg body weight.
The administration of 250 and 3000mg /kg body weight of test material did not affect the epididymal sperm concentration when compared with the control group. In contrast, the epididymal sperm concentration was significantly decreased in the 6000mg /kg body weight group, compared with the control or two lower dose groups. In the acrosome reaction assays, there was no statistically significant difference between the control and three different treated groups (p>0.05). No significant differences were found among testes of 250, 3000, 6000 mg/kg groups as compared with the control group (p>0.05) The weight of the epididymis plus vas deferens was significantly decreased only in the 6000mg /kg body weight of group as compared with the control (p<0.05), while the weight of the seminal vesicle decreased in all treated groups with a marked decrease in the 6000mg/kg body weight of MSG group (p<0.01). No marked changes in histology were noted in the testes of rats receiving 250mg/kg body weight of test material as compared with the control group However, a mild slouching of spermatogenic cells in the seminiferous tubular lumen was observed in approximately 10-15% of the seminiferous tubules obtained from eight animals administered with 3000mg /kg body weight of test material Moreover, mild sloughing of such seminiferous tubules with some vacuolization and some shrinkage of the interstitial tissues with wider empty spaces were noticed in approximately 40-45% of rats administered with 6000mg /kg body weight of test material. When compared to the control, the plasma testosterone levels were significantly lowered in 3000mg /kg body weight of test material (p<0.05) and of 6000mg/kg body weight of test material (p<0.01),whereas the testosterone levels in rats with 250mg /kg body weight of test material were normal. HenceNo Observed Adverse Effect Level (NOAEL) was considered to be below 3000mg/kg/day as no significant difference was observed at male reproductive function, whenmaleSprague-dawleyrats treated with test chemicalorally for 30 days. Butthe consumption of high dose test material must be avoided because it may cause partial infertility in male.
Based on the data available from different studies, test material did not showedreproductive toxicityat dose concentration 1000mg/kg /day. when male and female rats were treated with test material orally,Thus, comparing this value with the criteria ofCLP regulationtest materialis not likelyto classify as reproductive toxicant.
Effects on developmental toxicity
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Thus, comparing this value with the criteria of CLP regulation test material is not likely to classify as reproductive toxicant.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.